teva axsome - Search News

Axsome settles patent litigation with Teva

Business Insider · 1d

Shares in Biopharma Firm Axsome Surge Over 20% After Settling Teva Patent Dispute

Shares in biopharmaceutical group Axsome Therapeutics (AXSM) surged 23% today after it said it had settled a legal dispute with peer Teva

Zacks.com on MSN · 15h

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Shares of Axsome Therapeutics AXSM jumped 20.2% on Monday after the company announced that it has entered into a settlement agreement with Teva Pharmaceuticals TEVA related to patents for the psychiatry drug,

Seeking Alpha · 6h

Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade

Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.

1d

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

11h

Why Axsome Therapeutics Stock Is Soaring Today

Shares of Axsome Therapeutics ( AXSM 4.07%) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m. ET, but was ...

7hon MSN

Why Axsome Therapeutics (AXSM) Is Advancing Today

Axsome Therapeutics (AXSM) is climbing nearly 4% after Swiss bank UBS increased its price target on the shares to $133 from ...

13h

Axsome Therapeutics price target raised to $167 from $143 at BofA

BofA analyst Jason Gerberry raised the firm’s price target on Axsome Therapeutics (AXSM) to $167 from $143 and keeps a Buy rating on the shares ...

1don MSN

Why Axsome Therapeutics Stock Is Skyrocketing Today

Shares of Axsome Therapeutics ( AXSM 20.22%) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results